Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,507.20
(
-0.90%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
107.16
(
2.61%
)
Bitcoin
70,305.02
(
0.58%
)
News Focus
News Focus
Post# of 57560
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

davidal66

Send PM Follow Ignore
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

davidal66

Re: erbse24448 post# 22141

Wednesday, 11/26/2008 4:31:09 PM

Wednesday, November 26, 2008 4:31:09 PM

Post# of 57560
erbse24448... this one still is enrolling for ADHD: http://www.clinicaltrials.gov/ct2/show/NCT00610441?intr=%22ORG+26576%22&rank=2

I'm not sure what happened to the depression trial. I think there was a third in-house SGP/Organon trial for depression which was of longer duration for the backup to ORG24448 which is now being tested in ADHD. I think the patent exp. date on this compound is 2017-2018.

ps... happy thanksgiving to all....
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now